Lantern Pharma Inc.
LTRN
$1.79
$0.021.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.10% | 19.95% | 17.62% | 0.90% | -8.46% |
| Total Depreciation and Amortization | -23.47% | -32.76% | -42.03% | 36.27% | 8.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,337.17% | 118.52% | 26.83% | 775.99% | -11.92% |
| Change in Net Operating Assets | -158.78% | -218.38% | -71.49% | -38.27% | -55.92% |
| Cash from Operations | 21.21% | 21.16% | 11.99% | 2.15% | -17.11% |
| Capital Expenditure | 91.78% | 94.83% | 85.71% | 66.44% | 55.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.41% | 68.17% | 227.00% | 8,304.92% | 4,417.87% |
| Cash from Investing | -16.36% | 68.43% | 228.17% | 8,995.57% | 4,153.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 46,814.17% | 13,550.00% | 2,355.77% | 1,356.97% | -78.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 45,650.00% | 12,385.83% | 2,146.33% | 324.28% | 102.69% |
| Foreign Exchange rate Adjustments | 196.55% | 230.62% | 167.47% | -385.27% | -30.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.66% | 87.82% | 78.59% | 101.64% | 56.75% |